ABBV-085, an Antibody Drug Conjugate, in Subjects With Advanced Solid Tumors

Clinical trial NCT02565758 · COMPLETED

Trial details

NCT number: NCT02565758
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors Undifferentiated Pleomorphic Sarcoma Squamous Cell Carcinoma of the Head and Neck Carcinoma of the Breast

Start date: 2015-09-18
Primary completion: 2019-03-25
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.